http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020155910-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90348a429ffa25bbd39a647ab0d9173e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0672
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074
filingDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b16b9d8deab69be6a5b77bde0c538e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb89ab82c618669a7d561075cc265ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809c7fb712c68134f22076352e58d6e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9135c46d274f3ce9637b5fbdff55133f
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020155910-A1
titleOfInvention Composition and application thereof
abstract Provided is a composition and an application thereof. The composition is used to prepare a medium for inducing differentiation of human pluripotent stem cells to liver precursor cells. By means of screening active components, optimizing the composition ratio and adding a GSK3-beta inhibitor, a Nodal activator, a BMP activator, a BMP inhibitor and a Hedgehog activator, human pluripotent stem cells are induced to differentiate to liver precursor cells. The process is simple and efficient, the content of positive cells is high, and the cost of cell differentiation is reduced. The invention can be used for research and application in drug development and regenerative medicinal treatment, and has broad application prospects.
priorityDate 2019-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220586-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017048193-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226971764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227593366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5318591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265

Total number of triples: 35.